SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: IRWIN JAMES FRANKEL who wrote (4614)10/23/2000 3:38:51 PM
From: tommysdad  Read Replies (2) | Respond to of 10280
 
<<So did we miss something? >>

Well, here's what I missed:

According to today's Biocentury, R-fluoxetine is actually 8 times less (that's right, less) potent than S-fluoxetine. That's why they were shooting for a higher dose.

I'm going to dig around for confirmation of this little nugget, but would appreciate anyone who runs across info first.

Meanwhile, S-fluoxetine is still in the pipeline.

TD